Computational drug discovery meets translational medicine at the intersection of virology, metabolism, and therapeutic innovation.
Three interconnected research streams driving innovation in viral therapeutics
Computational approaches to next-generation antivirals using AI-driven drug design and systems modeling of viral-host metabolism.
Understanding Long COVID, ME/CFS, and recovery through investigation of metabolic dysfunction and mitochondrial pathology.
From algorithm to clinic—bridging computational discoveries with bench-to-bedside programs and clinical trials.
The Institute for Viral Metabolism and Therapeutics (IVMT) is a center of the Li Ka Shing Institute of Virology at the University of Alberta, with a strategic computational partnership with Politecnico di Torino.
Our unique model combines world-class wet lab research in Edmonton with cutting-edge computational drug discovery in Turin, creating a seamless pipeline from basic research to clinical translation.
Publication
Our team publishes in Biomolecules showing mitochondrial reactive oxygen species as a unifying mechanism in Long COVID and spike protein-associated injury...
Read More
Publication
New review in Biomedicine & Pharmacotherapy details therapeutic approaches targeting metabolic dysfunction in PACVS patients...
Read More
Publication
Computational drug discovery identifies potent frameshift inhibitors effective against multiple coronavirus strains...
Read MoreCollaborating with world-leading institutions across four countries
Li Ka Shing Institute of Virology
Edmonton, AB, Canada
Politecnico di Torino
Turin, Italy
Open Source Medicine Americas
Prospera ZEDE, Bay Islands, Honduras
We're building an international team of scientists, clinicians, and innovators dedicated to understanding viral metabolism and developing next-generation treatments.